Serum and muscle interleukin-15 levels decrease in aging mice: Correlation with declines in soluble interleukin-15 receptor alpha expression

Experimental Gerontology

Volumn 45, Issue 2, 2010, Pages 106-112

  Quinn, LeBris S ^a,b   Anderson, Barbara G ^a,b   Strait Bodey, Lena ^a   Wolden Hanson, Tami ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Body composition; Cytokines; IL 15; IL 15 receptors; Sarcopenia; Skeletal muscle; Soluble IL 15 alpha receptor

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; MESSENGER RNA;

AGING; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; MALE; MOUSE; MUSCLE MASS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGING; ANIMALS; BODY COMPOSITION; BODY WEIGHT; GENE EXPRESSION; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MODELS, ANIMAL; NEOPLASMS; QUADRICEPS MUSCLE; RNA, MESSENGER; SARCOPENIA; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 74649084925     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.10.012     Document Type: Article

References (36)

1. Ajuwon K.M., and Spurlock M.E. Direct regulation of lipolysis by interleukin-15 in primary pig adipocytes. Am. J. Physiol. 287 (2004) R608-R611
2. Alvarez B., Carbo N., Lopez-Soriano J., Drivdahl R.H., Busquets S., Lopez-Soriano F.J., Argiles J.M., and Quinn L.S. Effects of interleukin-15 on adipose mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochem. Biophys. Acta 1570 (2002) 33-37
3. Andras S.C., Power J.B., Cocking E.C., and Davey M.R. Strategies for signal amplification in nucleic acid detection. Mol. Biotechnol. 19 (2001) 29-44
4. Baumgartner R.N. Body composition in healthy aging. Ann. NY Acad. Sci. 904 (2000) 437-448
5. Bergamaschi C., Rosati M., Jalah R., Valentin A., Kulkarni V., Alicea C., Zhang G.-N., Patel V., Felber B.K., and Pavlakis G.N. Intracellular interaction of interleukin-15 with its receptor α during production leads to mutual stabilization and increased bioactivity. J. Biol. Chem. 283 (2008) 4189-4199
6. Budagian V., Bulanova E., Paus R., and Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17 (2006) 259-280
7. Bulanova E., Budagian V., Duitman E., Orinska A., Krause H., Rückert R., Reiling N., and Bulfone-Paus S. Soluble IL-15Rα is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15. J. Biol. Chem. 282 (2007) 13167-13179
8. Bunout D., de la Maza M.P., Barrera G., Leiva L., Gattas V., and Hirsch S. Assessment of sarcopenia: longitudinal versus corss sectional body composition. Aging Clin. Exp. Res. 19 (2007) 295-299
9. Carbó N., López-Soriano J., Costelli P., Busquets S., Alvarez B., Baccino F.M., Quinn L.S., López-Soriano F.J., and Argilés J.M. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Brit. J. Cancer 83 (2000) 526-531
10. Carbó N., López-Soriano J., Costelli P., Alvarez B., Busquets S., Baccino F.M., Quinn L.S., López-Soriano F.J., and Argilés J.M. Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochem. Biophys. Acta 1526 (2001) 17-24
11. Di Renzo L., Bigioni M., Bottini F.G., Del Grobbo V., Premrov M.G., Cianci R., and De Lorenzo A. Normal weight obese syndrome: role of single nucleotide polymorphism of IL-15Rα and MTHFR 677 → T genes in the relationship between body composition and resting metabolic state. Eur. Rev. Med. Pharm. Sci. 10 (2006) 235-245
12. Eisenman J., Ahdieh M., Beers C., Brasel K., Kennedy M.K., Le T., Bonnert T.P., Paxton R.J., and Park L.S. Interleukin-15 interactions with interleukin-15 receptor complexes: characterization and species specificity. Cytokine 20 (2002) 121-129
13. Facchini F.S., Hua N., Abbasi F., and Reaven G.M. Insulin resistance as a predictor of age-related diseases. J. Clin. Endocrinol. Metab. 86 (2001) 3574-3578
14. Fehniger T.A., and Caligiuri M.A. Interleukin-15: biology and relevance to human disease. Blood 97 (2001) 14-32
15. Figueras M., Busquets S., Carbó N., Barreiro E., Almendro V., Argilés J.M., and López-Soriano F.J. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats. FEBS Lett. 569 (2004) 201-206
16. Flagella M., Bui S., Zheng Z., Nguyen C.T., Zhang A., Pastor L., Ma Y., Yang W., Crawford K.L., McMaster G.K., Witney F., and Luo Y. A multiplex branched DNA assay for parallel quantitative gene expression profiling. Anal. Biochem. 352 (2006) 50-60
17. Gangemi S., Basile G., Monti D., Merendino R.A., Di Pasquale G., Bisigano U., Nicita-Mauro N., and Franceschi C. Age-related modifications in circulating IL-15 levels in humans. Mediators Inflamm. 4 (2005) 245-247
18. Goodpaster B.H., Park S.W., Harris T.B., Kritchevsky S.G., Nevit M., Schwartz A.V., Simonisck E.M., Tylavsky F.A., Visser M., and Newman A.B. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. 61A (2006) 1059-1064
19. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M., Johnson L., Alderson M.R., Watson J.D., Anderson D.M., and Giri J. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264 (1994) 965-968
20. Harcourt L.J., Holmes A.G., Gregorevic P., Schertzer J.D., Stupka N., Plant D.R., and Lynch G.S. Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice. Am. J. Pathol. 166 (2005) 1131-1141
21. Lebrun C.E.I., van der Schouw Y.T., de Jong F.H., Grobbee D.E., and Lamberts S.W. Fat mass rather than muscle strength is the major determinant of physical function and disability in postmenopausal women younger than 75 years of age. Menopause 13 (2006) 474-481
22. Lesser G.T., Deutsch S., and Markofsky J. Aging in the rat: longitudinal and cross-sectional studies of body composition. Am. J. Physiol. 225 (1973) 1472-1478
23. Marzetti E., Carter C.S., Wohlgemuth S.E., Lees H., Giovannini S., Anderson B., Quinn L.S., and Leewenburgh C. Modulation of skeletal muscle IL-15 expression and death-receptor apoptotic signaling by aging and calorie restriction. Mech. Aging Dev. 130 (2009) 272-280
24. Mortier E., Quemener A., Vusio P., Lorenzen I., Boublik Y., Grotzinger J., Plet A., and Jacques Y. Soluble IL-15R alpha-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma: hyper-agonist IL-15-IL-15R alpha fusion proteins. J. Biol. Chem. 281 (2006) 1612-1619
25. Nielsen A.R., Mounier R., Plomgaared P., Mortensen O.H., Penkowa M., Speerschneider T., Pilegaard H., and Pedersen B.K. Expression of interleukin-15 in human skeletal muscle-effect of exercise and muscle fibre type composition. J. Physiol. 584 (2007) 305-312
26. Nielsen A.R., Hojman P., Erikstrup C., Fischer C.P., Plomgaard P., Mounier R., Mortensen O.H., Broholm C., Taudorf S., Krogh-Madsen R., Lindegaard B., Petersen A.M.W., Gehl J., and Pedersen B.K. Association between interleukin-15 and obesity: interelukin-15 as a potential regulator of fat mass. J. Clin. Endo. Metab. 93 (2008) 4486-4493
27. Pistilli E.E., and Alway S.E. Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats. Biochem. Biophys. Res. Commun. 373 (2008) 20-24
28. Pistilli E.E., Siu P.M., and Alway S.E. Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy. Am. J. Physiol. 292 (2007) C1298-C1304
29. Pistilli E.E., Devaney J.M., Gordish-Dressman H., Bradbury M.K., Seip R.L., Thompson P.D., Angelopoulos T.J., Clarkson P.M., Myna N.M., Pescatello L.S., Visich P.S., Zoeller R.F., Gordon P.M., and Hoffman E.P. Interelukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine 43 (2008) 45-53
30. Quinn L.S. Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition. J. Anim. Sci. 86 (2008) E75-E83
31. Quinn L.S., Anderson B.G., Drivdahl R.H., Alvarez B., and Argilés J.M. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp. Cell Res. 280 (2002) 55-63
32. Quinn L.S., Strait-Bodey L., Anderson B.G., Argilés J.M., and Havel P.J. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol. Int. 29 (2005) 449-457
33. Quinn L.S., Anderson B.G., Strait-Bodey L., Stroud A.M., and Argilés J.M. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am. J. Physiol. 296 (2009) E191-E202
34. Riechman S.E., Balasekaran G., Roth S.M., and Ferrell R.E. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J. Appl. Physiol. 97 (2004) 2214-2219
35. Rubinstein M.P., Kovar M., Purton J.F., Cho J.-H., Boyman O., Surh C.D., and Sprent J. Convertng IL-15 to a superagonist by binding to soluble IL-15Rα. Proc. Natl. Acad. Sci. USA 103 (2006) 9166-9171
36. Tagaya Y., Kurys G., Thies T.A., Losi J.M., Azimi N., Hanover J.A., Bamford R.N., and Waldmann T.A. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl. Acad. Sci. USA 94 (1997) 14444-14449